The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal ...

Motif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its ...

Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug ...

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based ...

The European Organisation for Research and Treatment of Cancer (EORTC) has renewed and extended its partnership with Medidata ...

Beate Mueller-Tiemann is chief technology officer at Cytiva. With a passion for science and an ‘eternal technology optimist’, ...

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) ...